发明名称 |
Prevention of fetal alcohol syndrome and neuronal cell death with adnf polypeptides |
摘要 |
This invention relates to a method for reducing a condition associated with fetal alcohol syndrome in a subject who is exposed to alcohol in utero with an ADNF polypeptide. In particular, the present invention relates to a method of reducing a condition associated with fetal alcohol syndrome in a subject who is exposed to alcohol in utero with a combination of ADNF I and ADNF III polypeptides. The present invention further relates to a method for reducing neuronal cell death by contacting neuronal cells with a combination of ADNF I and ADNF III polypeptides. Still further, the present invention relates to a pharmaceutical composition comprising a combination of ADNF I and ADNF III polypeptides. |
申请公布号 |
AU3624800(A) |
申请公布日期 |
2000.09.28 |
申请号 |
AU20000036248 |
申请日期 |
2000.03.10 |
申请人 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED;RAMOT OF TEL AVIV UNIVERSITY |
发明人 |
DOUGLAS E BRENNEMAN;CATHERINE Y. SPONG;ILLANA GOZES;MERAV BASSAN;RACHEL ZAMOSTIANO |
分类号 |
A61K38/18;A61P25/28;A61P25/32 |
主分类号 |
A61K38/18 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|